Pharma Mergers Could Stifle Drug Innovation: AAI
Troubled by consolidation in the pharmaceutical industry, the American Antitrust Institute has called on federal regulators to thoroughly examine the consequences of the proposed Pfizer Inc.-Wyeth Inc. and Merck & Co.-Schering-Plough...To view the full article, register now.
Already a subscriber? Click here to view full article